Vincristine saturation of cellular binding sites and its cytotoxic activity in human lymphoblastic leukemia cells: Mechanism of inoculum effect

Biochemical Pharmacology

Volumn 55, Issue 8, 1998, Pages 1229-1234

  Kobayashi, Hiroyuki ^a   Takemura, Yuzuru ^a   Holland, James F ^a   Ohnuma, Takao ^a  

^a Department of Medicine   (United States)

Author keywords

Cell density; Cellular binding sites; Cytotoxicity; Inoculum effect; Vincristine

Indexed keywords

VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BINDING SITE; CELL DENSITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG BINDING; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032523137     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00615-1     Document Type: Article

References (23)

1. Ohnuma T, Arkin H, Holland JF. Effects of cell density on drug-induced cell kill kinetics in vitro (inoculum effect). Br J Cancer. 54:1986;415-421.
2. Takemura Y, Kobayashi H. Miyachi H, Hayashi K, Sekiguchi S and Ohnuma T, The influence of tumor cell density on cellular accumulation of doxorubicin or cisplatin in vitro. Cancer Chemother Pharmacol. 27:1991;417-422.
3. Kobayashi H, Takemura Y, Ohnuma T. Relationship between tumor cell density and drug concentration and the cytotoxic effects of doxorubicin or vincristine Mechanism of inoculum effects . Cancer Chemother Pharmacol. 31:1992;6-10.
4. Basker MJ, Edmondson RAE, Sutherland R. Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of Pseudomonas aeruginosa and Klebsiella aerogenes. Infection. 7:1979;67-73.
5. Bodey GP, Pan T. Mezlocillin In vitro studies of a new broad-spectrum penicillin . Antimicrob Agents Chemother. 11:1977;74-79.
6. Minowada J, Ohnuma T, Moore GE. Rosette-forming human lymphoid cell lines 1. Establishment and evidence for origin of thymus-derived lymphocytes . J Natl Cancer Inst. 49:1972;891-895.
7. Totsuka K, Oshimi K, Mizoguchi H. Vindesine receptors in cells of a human leukaemia cell line. Br J Cancer. 46:1982;392-396.
8. Harlow E and Lane D, Preparing total cell lysates for immunoblotting. Antibodies. A Laboratory Manual, pp. 481-482. Cold Spring Harbor Laboratory Press, Plainview, NY, 1988.
9. Watanabe N, Kamei S, Ohkubo A, Yamanaka M, Ohsawa S, Makino K, Tokuda K. Urinary protein as measured with a pyrogallol red-molybdate complex manually and in a Hitachi 726 automated analyzer. Clin Chem. 32:1986;1551-1554.
10. Rosenthal HE. Graphical method for the determination and presentation of binding parameters in a complex system. Anal Biochem. 20:1967;525-532.
11. Ferguson PJ, Cass CE. Differential cellular retention of vincristine and vinblastine by cultured human promyelocytic leukemia HL-60/Cl cells The bases of differential toxicity . Cancer Res. 45:1985;5480-5488.
12. Pierré A, Pérez V, Léonce S, Boutin JA, Saint-Dizier D, Hautefaye P, Lavielle G, Atassi G. Relationship between the cellular accumulation and the cytotoxicity of S12363, a new vinca alkaloid derivative. Cancer Chemother Pharmacol. 29:1992;367-374.
13. Bai RL, Pettit GR, Hamel E. Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites. J Biol Chem. 265:1990;17141-17149.
14. Singer WD, Himes RH. Cellular uptake and tubulin binding properties of four Vinca alkaloids. Biochem Pharmacol. 43:1992;545-551.
15. Luduena RF, Banerjee A, Khan IA. Tubulin structure and biochemistry. Curr Opin Cell Biol. 4:1992;53-57.
16. van Tellingen O, Sips JHM, Beijnen JH, Bult A, Nooijen WJ. Pharmacology, bio-analysis and pharmacokinetics of the vinca alkaloids and semi-synthetic derivatives (review). Anticancer Res. 12:1992;1699-1716.
17. Freireich EJ, Gehan EA, Sulman D, Boggs DR, Frei E III. The effect of chemotherapy on acute leukemia in the human. J Chronic Dis. 14:1961;593-608.
18. Wierzba K, Sugiyama Y, Okudaira K, Iga T, Hanano M. Tubulin as a major determinant of tissue distribution of VCR. J Pharm Sci. 76:1987;872-875.
19. Alberts DS and Chen H-SG, Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay. In: Cloning of Human Tumor Stem Cells (Ed. Salmon S), pp. 351-359. Alan R. Liss, New York, 1980.
20. Owellen RJ, Root M, Hains FO. Pharmacokinetics of vindesine and vincristine in humans. Cancer Res. 37:1977;2603-2607.
21. Hammond D, Sather H, Nesbit M, Miller D, Coccia P, Bleyer A, Lukens J, Siegel S. Analysis of prognostic factors in acute lymphoblastic leukemia. Med Pediatr Oncol. 14:1986;124-134.
22. Sather HN. Statistical evaluation of prognostic factors in ALL and treatment results. Med Pediatr Oncol. 14:1986;158-165.
23. Kano Y, Ohnuma T, Okano T, Holland JF. Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture. Cancer Res. 48:1988;351-356.